SCHEMBL6813134

SCHEMBL6813134

CC(C)(C)[Si](C)(C)OCCCN(C1(C(=O)OCc2ccccc2)CCCC1)S(=O)(=O)c1ccc(Oc2ccc(F)cc2)cc1

nearest known ligand 0.47

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
MMP1 P03956 3/20 0.47
FFAR1 O14842 1/20 0.38
NR3C1 P04150 1/20 0.37
RORC P51449 4/20 0.37
NPSR1 Q6W5P4 1/20 0.35
P2RX7 Q99572 1/20 0.34
MMP13 P45452 2/20 0.33
NR1I2 O75469 1/20 0.33
LTA4H P09960 1/20 0.33
CACNA1H O95180 2/20 0.32
CACNA1B Q00975 2/20 0.32
KEAP1 Q14145 1/20 0.32
NFE2L2 Q16236 1/20 0.32
PTGES O14684 1/20 0.32
KMT2A Q03164 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4615702 0.94 MMP1 (0.39) MMP1RORCNPSR1NR1I2KEAP1
SCHEMBL13898761 0.87 NR3C1 (0.37) MMP1NR3C1P2RX7MMP13PTGES
SCHEMBL6809611 0.85 MMP1 (0.54) MMP1FFAR1NR3C1RORCNPSR1
SCHEMBL6813135 0.83 MMP1 (0.67) MMP1FFAR1NR3C1RORCNPSR1
SCHEMBL6813465 0.81 MMP1 (0.55) MMP1FFAR1NR3C1RORCNPSR1
SCHEMBL4614633 0.78 MMP1 (0.44) MMP1RORCNR1I2KEAP1NFE2L2
SCHEMBL8011711 0.78 CAMK2A (0.37) MMP1MMP13KEAP1NFE2L2PTGES
SCHEMBL4616560 0.76 MMP1 (0.56) MMP1RORCNPSR1NR1I2KEAP1
SCHEMBL4616532 0.75 MMP1 (0.49) MMP1RORCKEAP1NFE2L2KMT2A
SCHEMBL6872275 0.73 MMP1 (0.43) MMP1FFAR1NR3C1RORCNPSR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1415984-A1 Aryloxyarylsulfonylamino hydroxamic acid derivatives Pfizer Products Inc. (US) 2004-05-06 EP disclosed
EP-1003720-B1 ARYLOXYARYLSULFONYLAMINO HYDROXAMIC ACID DERIVATIVES PFIZER PROD INC (US) 2004-03-31 EP disclosed
US-6214872-B1 ANTIARTHRITIC AND ANTICARCINOGENIC AGENTS PFIZER INC. 2001-04-10 US disclosed
EP-1003720-A1 ARYLOXYARYLSULFONYLAMINO HYDROXAMIC ACID DERIVATIVES Pfizer Products Inc. (US) 2000-05-31 EP disclosed
WO-1999007675-A1 ARYLOXYARYLSULFONYLAMINO HYDROXAMIC ACID DERIVATIVES PFIZER PRODUCTS INC. (US) 1999-02-18 WO disclosed